Optimum duration of clopidogrel pretreatment before PCI
Pippa Murdie
This article has no abstract so we have provided the first paragraph of the full text.
Thienopyridines are commonly administered before percutaneous coronary intervention (PCI) to prevent thrombotic complications, but no consensus has been reached regarding the optimum treatment duration. Steinhubl and co-workers report on the relationship between duration of pretreatment with clopidogrel—a thienopyridine derivative—and the occurrence of ischemic complications.
Full text of this article is available with one of the following:
- Personal subscription Purchase your own personal subscription to this journal. Already a subscriber? Please log in for immediate access.
- 7 day single article pass for US$18 In order to purchase this article you must be a registered user. Please register or log in.
- Site licence Learn more about institutional site licences
Current Subscribers
Please log in to access the full text article using the login box at the top of the page.
